NIH Reporter #75N93025D00026-0-9999-1

Solicitation for Evaluation and Testing Services for Vaccines and Biologics for Infectious Diseases

This opportunity is issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, for evaluation and testing services related to vaccines and biologics for infectious diseases and bioterrorism agents. - Government Buyer: - National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) - Location: San Antonio, TX (Texas Biomedical Research Institute) - Products/Services Requested: - Comprehensive evaluation and testing services for vaccine and biologic candidates - Services span from early feasibility studies to support for Biologics License Application (BLA) and Investigational New Drug (IND) submissions - Support for full product development lifecycle for vaccines and biologics targeting infectious agents - Unique/Notable Requirements: - Ability to provide end-to-end product development services, including regulatory support - Focus on infectious diseases and agents of bioterrorism - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Quantities and Part Numbers: - No specific quantities or part numbers provided

Description

This solicitation is for evaluation and testing services for vaccines and biologics aimed at infectious diseases and agents of bioterrorism. The project provides product development services from early feasibility studies through activities required for BLA and IND submissions. The contract duration is from September 30, 2025, to September 29, 2035. The services are to be performed by the Texas Biomedical Research Institute located in San Antonio, TX.

View original listing